PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Symptom | C0796095|c syndrome |
| Sentences | 56 |
| PubMedID- 21118396 | Background: moderate alcohol consumption may have certain beneficial effects against non-alcoholic fatty liver disease, which is associated with metabolic syndrome. |
| PubMedID- 26399788 | Nonalcoholic fatty liver disease is associated with metabolic syndrome and has the unique characteristic of excess lipid accumulation in liver. |
| PubMedID- 25911912 | The aim of the study was to evaluate the main features of the gastrointestinal myoelectrical activity (gi mea) in patients with nonalcoholic fatty liver disease (nafld) associated with metabolic syndrome (ms). |
| PubMedID- 26088821 | In metabolic syndrome, the development of nonalcoholic fatty liver disease (nafld) is known. |
| PubMedID- 24834224 | The mean body mass index of the 22 cases was 31.18 +/-5.7 and non-alcoholic fatty liver disease was associated with the metabolic syndrome in these subjects. |
| PubMedID- 24044566 | Serum adiponectin, leptin, resistin and rbp4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease. |
| PubMedID- 23077931 | The central role of the non alcoholic fatty liver disease in metabolic syndrome. |
| PubMedID- 20814441 | Nonalcoholic fatty liver disease (nafld) is associated with metabolic syndrome and insulin resistance . |
| PubMedID- 26307490 | Hepatic encephalopathy (he) is a complex neuropsychiatric syndrome affecting patients with liver diseases, mainly those with liver cirrhosis. |
| PubMedID- 21413092 | Obesity, which is related to metabolic syndrome and is associated with liver disease, represents an epidemic problem demanding effective therapeutic strategies. |
| PubMedID- 21698231 | Non-alcoholic fatty liver disease (nafld) is associated with the metabolic syndrome, a cluster of factors associated with the development of insulin resistance and atherosclerosis which has reached epidemic proportions in the developed world 1. |
| PubMedID- 24713801 | Background: although non-alcoholic fatty liver disease (nafld) is associated with obesity and metabolic syndrome (ms), it may also be present in lean individuals. |
| PubMedID- 23897104 | Background: the association of plasma cardiovascular risk markers and metabolic syndrome (mets) with non-alcoholic fatty liver disease (nafld) has not been well defined. |
| PubMedID- 23419204 | Objective: while nonalcoholic fatty liver disease (nafld) is associated with the metabolic syndrome, it is not known if nafld plays an independent role in the atherogenic dyslipidemia phenotype. |
| PubMedID- 24748893 | Fatty liver disease is often associated with the metabolic syndrome defined as hyperinsulinemia or a fasting blood glucose level > 100 mg/dl or a blood glucose level > 200 mg/dl 2h after an oral glucose tolerance test plus either obesity, dyslipidemia or hypertension (4, 5). |
| PubMedID- 25988570 | Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease. |
| PubMedID- 24765691 | An association of non-alcoholic fatty liver disease with insulin resistant metabolic syndrome and hypothyroidism has been suggested. |
| PubMedID- 22383235 | He is a neuropsychiatric syndrome that develops in patients with severe liver diseases, with portosystemic shunt surgery in the form of diffuse mild brain edema. |
| PubMedID- 25960770 | A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with non-alcoholic fatty liver disease. |
| PubMedID- 26117210 | Objective: in patients with familial combined hyperlipidemia (fchl), without metabolic syndrome (ms), occurrence of non-alcoholic fatty liver disease (nafld) is related to a specific pro-inflammatory profile, influenced by genetic traits, involved in oxidative stress and adipokine secretion. |
| PubMedID- 22844333 | Nonalcoholic fatty liver disease is associated with metabolic syndrome. |
| PubMedID- 24793377 | In conclusion, in contrast to bpa, bps does not appear to induce the metabolic syndrome that may lead to non-alcoholic fatty liver disease (nafld), in vitro. |
| PubMedID- 22813407 | Association of nonalcoholic fatty liver disease with metabolic syndrome in indian population. |
| PubMedID- 23227347 | Nonalcoholic fatty liver disease is closely associated with features of metabolic syndrome and likely represents the hepatic manifestation of the metabolic syndrome. |
| PubMedID- 21212755 | Nonalcoholic fatty liver disease is associated with the metabolic syndrome. |
| PubMedID- 22824769 | The study therefore highlights the need to educate physicians on how to diagnose cirrhosis non-invasively and correlate features of metabolic syndrome with chronic liver disease. |
| PubMedID- 22824914 | In patients with metabolic syndrome, the prevalence of non-alcoholic fatty liver disease (nafld) is two- or three time higher than in general population (marchesini et al., 2003). |
| PubMedID- 19730107 | Background: hepatic encephalopathy (he) is a reversible neuropsychiatric syndrome in patients with liver disease. |
| PubMedID- 23032980 | Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in korean adults. |
| PubMedID- 20308604 | This study shows the effectiveness and safety of rituximab in mc syndrome with advanced liver disease. |
| PubMedID- 22644007 | Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome. |
| PubMedID- 22546752 | Gamma-glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome. |
| PubMedID- 24562590 | Hepatic encephalopathy (he) is a neuropsychiatric syndrome which develops in patients with severe liver diseases and/or portal-systemic shunting. |
| PubMedID- 22103753 | Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: impact of nonalcoholic fatty liver disease. |
| PubMedID- 21387764 | Non-alcoholic fatty liver disease (nafld) in patients with metabolic syndrome and type 2 diabetes mellitus. |
| PubMedID- 24850609 | Effect of gene polymorphism of ppargamma2 regulatory proteins on the metabolic syndrome in children with nonalcoholic fatty liver disease and obesity. |
| PubMedID- 24933975 | Efficiency of ursodeoxycholic acid therapy in non-alcoholic fatty liver disease associated with metabolic syndrome. |
| PubMedID- 20645852 | The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. |
| PubMedID- 24531850 | Evolving information suggests that the metabolic syndrome with non-alcoholic liver disease may be an important cause of hcc in addition to viral hepatitis and alcohol-induced liver disease. |
| PubMedID- 22884916 | Background: nonalcoholic fatty liver disease is closely associated with metabolic syndrome and cardiovascular disease (cvd). |
| PubMedID- 23066331 | Fatty liver, including non-alcoholic fatty liver disease, is closely associated with metabolic syndrome (ms). |
| PubMedID- 25430922 | A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation. |
| PubMedID- 22135029 | It is important to analyse the morphologic spectrum of bile duct changes in non-biliary diseases as a link has been reported between intrahepatic cholangiocarcinoma and chronic liver disease associated with viral hepatitis, metabolic syndromes and with alcohol abuse. |
| PubMedID- 24665862 | Management of fatty liver disease with the metabolic syndrome. |
| PubMedID- 23935723 | Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. |
| PubMedID- 25926979 | The presence of multiple features of the metabolic syndrome is associated with progressive liver disease . |
| PubMedID- 23962027 | High ggt may be a marker of non-alcoholic fatty liver disease, which is associated with the metabolic syndrome. |
| PubMedID- 23842720 | Non-alcoholic steatohepatitis (nash) is the progressive phenotype of non-alcoholic fatty liver disease associated with the metabolic syndrome. |
| PubMedID- 21330637 | Nonalcoholic fatty liver disease (nafld) occurs in patients with components of metabolic syndrome. |
| PubMedID- 24424211 | Non-alcoholic fatty liver disease (nafld) is associated with the metabolic syndrome, especially obesity, hyperlipidaemia and diabetes1, and is now the most common liver disease in both adults and children worldwide2. |
Page: 1 2